Skip to content
DraconiticResearch
Search Sources API
197,785 studies31 sourcesUpdated 33 min ago
Peer-reviewedCC BYSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Advances in assessment systems and non-pharmacological intervention strategies for cancer-related fatigue following transarterial chemoembolization in hepatocellular carcinoma: a narrative review.

5 affiliations
  1. 1Department of Nursing, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China. [email protected].
  2. 2Department of Nursing, Changhai Hospital, First Affiliated Hospital of Naval Medical University, Shanghai, 200433, China.
  3. 3Shanghai Songjiang Sijing Hospital, Shanghai, 201601, China.
  4. 4Department of Nursing, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
  5. 5Department of Nursing, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China. [email protected].

Abstract

Purpose

Transarterial chemoembolization (TACE) is a primary treatment for intermediate to advanced hepatocellular carcinoma (HCC); however, cancer-related fatigue (CRF) is a prevalent and distressing symptom following TACE that significantly impairs patients' recovery and health-related quality of life. This review aimed to systematically summarize the current evidence on CRF screening, assessment, and non-pharmacological interventions specifically tailored to the post-TACE HCC population, and to propose an integrated, nurse-led clinical management framework.Methods

A narrative review was conducted by systematically searching PubMed, Web of Science, and CNKI for literature published up to April 2026. The search encompassed peer-reviewed original research articles (including randomized controlled trials, cohort studies, cross-sectional studies, and meta-analyses), clinical practice guidelines, and expert consensus reports. The level of evidence for each intervention category was evaluated using the Oxford Centre for Evidence-Based Medicine (OCEBM) grading system. The literature search focused on CRF epidemiology, pathophysiology, validated assessment tools, non-pharmacological interventions (including exercise, psychosocial support, nutritional management, and traditional Chinese medicine therapies), and nursing management models in HCC patients following TACE.Results

CRF following TACE is a multifactorial symptom driven by treatment-induced inflammation, hepatic dysfunction, and psychological distress. Validated screening tools, including the Brief Fatigue Inventory (BFI), Cancer Fatigue Scale (CFS), and EORTC QLQ-C30 fatigue subscale, are recommended for routine use, though to the best of our knowledge, no CRF assessment tool developed specifically for the post-TACE HCC population has been validated to date. A structured screening pathway encompassing baseline assessment, perioperative monitoring, and long-term follow-up was identified as essential for early detection. Among non-pharmacological interventions, individualized exercise prescriptions (aerobic and resistance training) have been most consistently supported across randomised trials and meta-analyses for alleviating CRF, followed by cognitive behavioral therapy, mindfulness-based stress reduction, and nutritional support. Traditional Chinese medicine approaches, including acupoint massage, auricular acupressure, and moxibustion, showed preliminary potential but require further high-quality validation. A nurse-led multidisciplinary care model integrating assessment, individualized intervention planning, and continuous coordination has been proposed as a promising operational framework for CRF management, endorsed by international CRF practice frameworks.Conclusions

Effective management of CRF after TACE requires a comprehensive, evidence-based approach spanning standardized screening, multimodal non-pharmacological interventions, and a nurse-coordinated multidisciplinary care model. Integrating routine CRF assessment into standard TACE clinical pathways and developing TACE-specific assessment tools are priorities for future research and clinical practice.

Related

  1. Case Report: Rapidly fatal hepatic portal venous gas following transarterial chemoembolization for hepatocellular carcinoma
    Renshan Zhao, Bin Xie
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMCEurope PMC
  2. Enhanced Efficacy of Thalidomide‐Based Cocktail With Transarterial Chemoembolization in the Management of Unresectable Hepatocellular Carcinoma: A Multi‐Center Cohort Study
    Jinzhi Xu, Li Song, Yifan Kong +15
    MedCommPeer-reviewedCC BYFull textGeneral medicineEurope PMCPMC
  3. Lesion selection and external evaluation of clinical-imaging survival models after transarterial chemoembolization for hepatocellular carcinoma
    Z. Xu, A. Melek, E. Castillo +1
    medRxivPreprintCC BYFull textMedical imaging & radiologymedRxiv
  4. Transarterial Radioembolization Versus Chemoembolization for Unresectable Large Single Hepatocellular Carcinoma.
    Myungsu Lee, Minuk Kim, Jayoun Kim +3
    Korean journal of radiologyPeer-reviewedCC BY-NCFull textMedical imaging & radiologyEurope PMC
  5. Efficacy and safety of sintilimab plus bevacizumab with or without transarterial chemoembolization for unresectable hepatocellular carcinoma: a propensity score-matched retrospective cohort study
    Zizhuo Wang, Bailu Wu, Chunshu Wu +7
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textImmunologyGeneral medicineCrossrefDOAJ
BibTeX
@article{yang2026advances,
  title = {{Advances in assessment systems and non-pharmacological intervention strategies for cancer-related fatigue following transarterial chemoembolization in hepatocellular carcinoma: a narrative review.}},
  author = {Shiying Yang and Xuelei Yao and Yali Ren and Teng Ding and Jiamin Gao and Lin Shentu},
  journal = {Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer},
  year = {2026},
  month = oct,
  doi = {10.1007/s00520-026-11380-9},
  url = {https://europepmc.org/article/MED/42909630},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Advances in assessment systems and non-pharmacological intervention strategies for cancer-related fatigue following transarterial chemoembolization in hepatocellular carcinoma: a narrative review.
AU  - Shiying Yang
AU  - Xuelei Yao
AU  - Yali Ren
AU  - Teng Ding
AU  - Jiamin Gao
AU  - Lin Shentu
PY  - 2026
DA  - 2026/10/23
JO  - Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
DO  - 10.1007/s00520-026-11380-9
UR  - https://europepmc.org/article/MED/42909630
AB  - Purpose  Transarterial chemoembolization (TACE) is a primary treatment for intermediate to advanced hepatocellular carcinoma (HCC); however, cancer-related fatigue (CRF) is a prevalent and distressing symptom following TACE that significantly impairs patients' recovery and health-related quality of life. This review aimed to systematically summarize the current evidence on CRF screening, assessment, and non-pharmacological interventions specifically tailored to the post-TACE HCC population, and to propose an integrated, nurse-led clinical management framework.Methods  A narrative review was conducted by systematically searching PubMed, Web of Science, and CNKI for literature published up to April 2026. The search encompassed peer-reviewed original research articles (including randomized controlled trials, cohort studies, cross-sectional studies, and meta-analyses), clinical practice guidelines, and expert consensus reports. The level of evidence for each intervention category was evaluated using the Oxford Centre for Evidence-Based Medicine (OCEBM) grading system. The literature search focused on CRF epidemiology, pathophysiology, validated assessment tools, non-pharmacological interventions (including exercise, psychosocial support, nutritional management, and traditional Chinese medicine therapies), and nursing management models in HCC patients following TACE.Results  CRF following TACE is a multifactorial symptom driven by treatment-induced inflammation, hepatic dysfunction, and psychological distress. Validated screening tools, including the Brief Fatigue Inventory (BFI), Cancer Fatigue Scale (CFS), and EORTC QLQ-C30 fatigue subscale, are recommended for routine use, though to the best of our knowledge, no CRF assessment tool developed specifically for the post-TACE HCC population has been validated to date. A structured screening pathway encompassing baseline assessment, perioperative monitoring, and long-term follow-up was identified as essential for early detection. Among non-pharmacological interventions, individualized exercise prescriptions (aerobic and resistance training) have been most consistently supported across randomised trials and meta-analyses for alleviating CRF, followed by cognitive behavioral therapy, mindfulness-based stress reduction, and nutritional support. Traditional Chinese medicine approaches, including acupoint massage, auricular acupressure, and moxibustion, showed preliminary potential but require further high-quality validation. A nurse-led multidisciplinary care model integrating assessment, individualized intervention planning, and continuous coordination has been proposed as a promising operational framework for CRF management, endorsed by international CRF practice frameworks.Conclusions  Effective management of CRF after TACE requires a comprehensive, evidence-based approach spanning standardized screening, multimodal non-pharmacological interventions, and a nurse-coordinated multidisciplinary care model. Integrating routine CRF assessment into standard TACE clinical pathways and developing TACE-specific assessment tools are priorities for future research and clinical practice.
SN  - 0941-4355
SN  - 1433-7339
ER  -